Barton P. Bandy, President and CEO at ReShape Lifesciences Inc. (RSLS), sold 11,063 shares at $1.13 ($13K) on 2022-04-01, disclosed to the SEC on 2022-04-08.
Open-market sale of $13k RSLS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RSLS | SELL | 2022-06-06 | $11K | — | Filing → |
| RSLS | SELL | 2022-05-12 | $9K | — | Filing → |
| RSLS | SELL | 2022-03-02 | $7K | — | Filing → |